Clobetasol propionate
Clobex contains the active substance clobetasol propionate. This substance belongs to topical corticosteroids (or steroids). Topical corticosteroids are further divided into groups depending on their potency. Clobetasol propionate is a very potent corticosteroid. It should only be used on the skin. Topical steroids reduce redness, itching, and inflammation associated with skin lesions. Psoriasis of the scalp is caused by the rapid production of scalp skin cells. Clobex is used to treat psoriasis of the scalp, of moderate severity, in adults.
Using Clobex with other medicines may increase the risk of severe infections.
If the medicine has been prescribed for use in a child or adolescent under 18 years of age, the patient must visit their doctor weekly for control before continuing treatment.
The patient should tell their doctor about all medicines they have taken recently, including those available without a prescription.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Clobex has no influence or negligible influence on the ability to drive and use machines.
This medicine contains 100 mg of alcohol (ethanol) per gram, which is equivalent to 10% w/w. It may cause a burning sensation on damaged skin.
This medicine should always be used as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist. The usual daily dose of Clobex is about half a tablespoon (about 7.5 ml) of the medicine, sufficient to cover the scalp. If the doctor has not instructed otherwise, the patient should wash their hands and apply Clobex directly to the dry scalp once a day, making sure to cover and massage the medicine into the affected areas. The patient should avoid using too much Clobex and use the amount sufficient to cover the dry scalp. After applying the medicine, the patient should wash their hands thoroughly. The medicine should be left on the skin for about 15 minutes without covering the head, and then rinsed off and the hair dried as usual. A regular shampoo can be used if more shampoo is needed. The patient should not increase the dose of Clobex. The doctor will inform the patient how long to use Clobex for the treatment of scalp psoriasis. Treatment should not last longer than 4 weeks. However, if there is significant improvement in psoriasis at the end of treatment, the patient should consult their doctor. The patient should also inform their doctor if there is no improvement at the end of treatment. Treatment requires close monitoring - the patient should inform their doctor about the progress of treatment at regular intervals.
The doctor may prescribe Clobex again in the future, after a period of time when it was not used.
If the medicine has been prescribed for use in a child between 2 and 18 years of age, the patient should follow the doctor's instructions carefully. The patient must visit their doctor weekly for control before continuing treatment.
The patient should consult their doctor. This medicine is intended for use only on the scalp. It should not be ingested. In case of accidental ingestion, small amounts of shampoo are not harmful. In case of doubts, the patient should consult their doctor immediately.
The patient should not use a double dose to make up for a missed dose. The patient should use the medicine according to the previous schedule. If several doses have been missed, the patient should consult their doctor.
The patient should consult their doctor. There is a risk of worsening the disease in case of stopping treatment with Clobex, especially if the medicine has been used for a long time. In case of doubts related to the use of the medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Clobex can cause side effects, although not everybody gets them. Clobex may cause the following side effects. Common side effects(less than 1 in 10 patients)
Uncommon side effects(less than 1 in 100 patients)
Frequency not known(cannot be estimated from the available data):
Skin irritation symptoms, itching, hives, visibility of blood vessels, and skin thinning around the treated area are usually mild or moderate.
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be gathered on the safety of the medicine.
Page 4 5
The medicine should be stored out of sight and reach of children.
The medicine should not be used after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
The medicine should be stored in the original packaging to protect it from light.
Shelf life after first opening: 6 months.
The bottle should be discarded 6 months after first opening.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Clobex is a thick, translucent, colorless to light yellow liquid shampoo with an alcoholic odor.
Clobex is available on prescription.
The medicine is available in an HDPE bottle with a PP snap-on cap, containing 125 ml of shampoo, placed in a cardboard box.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Laboratorios Galderma, S.A., Serrano Galvache, 56, 28033 Madrid, Spain
Laboratoires Galderma, Z.I.- Montdésir, 74540, Alby-sur-Chéran, France
Galderma Laboratorium GmbH, Toulouser Allee 23a, 40211 Düsseldorf, Germany
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Spanish marketing authorization number, country of export: 658226.8
This medicinal product is authorized in the Member States under the following names:
United Kingdom (Northern Ireland), Italy, Ireland, and Portugal: Etrivex 500 micrograms/g, shampoo
France, Germany, Belgium, Poland, Spain, Hungary, Netherlands, Sweden, Denmark, Austria, Luxembourg, Iceland, Czech Republic, Norway, Greece, Slovakia, and Finland: Clobex 500 micrograms/g, shampoo.
[Information about the trademark]
Page 5 5
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.